Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression

YONG-MIN NA; JIN-SEONG CHO; MIN-HO PARK

doi:10.21873/anticanres.15387

Research ArticleClinical Studies

Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression

YONG-MIN NA, JIN-SEONG CHO and MIN-HO PARK

Anticancer Research November 2021, 41 (11) 5713-5721; DOI: https://doi.org/10.21873/anticanres.15387

YONG-MIN NA

1Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

JIN-SEONG CHO

2Department of Surgery, Chonnam National University Hospital, Gwangju, Republic of Korea;

3Department of Surgery, Chonnam National University Medical School, Gwangju, Republic of Korea

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: sabiston@hotmail.com

MIN-HO PARK

1Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea;

3Department of Surgery, Chonnam National University Medical School, Gwangju, Republic of Korea

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 41, Issue 11

November 2021

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 3 + 10 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression

YONG-MIN NA, JIN-SEONG CHO, MIN-HO PARK

Anticancer Research Nov 2021, 41 (11) 5713-5721; DOI: 10.21873/anticanres.15387